risk assessment

| Article

Practitioners end up at risk in drug testing because they lack knowledge of the policies that payors put out on medical necessity. They also can get into a lot of trouble if they don’t understand the mechanics of the clinical laboratory regarding presumptive testing and definitive testing. It’s...

| Article

In what the authors say is the first response to an unmet need, an expert panel from Johns Hopkins has published a set of 20 operation-specific opioid prescribing guidelines. In general, the consensus guidance represents a reduction from current prescribing practice, and the authors note that this...

| Article

New policies and training invoked by Navy Medicine, providing medical services to sailors, Marines, and family members, are designed to strike a balance between ensuring safe use of opioids and preserving access to them for the treatment of chronic pain. Patients in the care of Navy Medicine will...

| Video

Too often, prescribers are the last to learn of an overdose event and worse, fail to take action once notified. Attorney Bolen outlines policies and protocols that practitioners can implement to proactively signal their intent to get things right when they go wrong.

| Video

Opioid reduction may be necessary in certain patients due to safety risk. Certain patients may be resistant to medication change for a number of physical and psychosocial factors. This presentation aims to provide clinicians with concrete examples of patient centered approaches to handling...

| Video

In addition to other shortcomings, current prescribing guidelines are particularly ill-suited to the needs and challenges of patients already on opioid therapy. Drs. Heit and Gourlay discuss the roots of the problem and the role of primary care as talented amateurs in addiction medicine.

| Video

Women with chronic pelvic pain frequently endure long delays in referral to appropriate specialties for diagnosis and care. In this segment, a pain medicine psychologist and a pain medicine specialist outline what primary care should know about the epidemiology, risk factors and etiology of various...

| Video

Opioid induced respiratory depression is associated with over 16,000 deaths in the US each year, and the risks of opioid therapy are not fully understood by many prescribers. Dr. Fudin reviews some of the unanticipated concerns, with a focus on assessing and managing risk for respiratory depression....

| Video

The legal landscape for prescribers of controlled medications for pain and addiction is fraught with risk. Attorney Michael Barnes outlines best practices for prescribing clinicians to protect their patients from harm and themselves from criminal and civil liability.

| Video

In addition to other shortcomings, current prescribing guidelines are particularly ill-suited to the needs and challenges of patients already on opioid therapy. Drs. Heit and Gourlay discuss the roots of the problem and the role of primary care as talented amateurs in addiction medicine.

Subscribe to risk assessment

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.